RxDoctor Payments DataLook up a doctor →

Jonathan Staben, MD

Family Medicine · Cheney, WANPI 1720071889

Payments from drug & device makers

$2,492,049in general payments, 2019–2025

Across 453 payments — averaging $5501.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$997K
  • Merck$722K
  • Bavarian Nordic A/s$333K
  • Janssen Research & Development, LLC$114K
  • Novavax Inc$75K
  • Organon$58K
  • plus $193K from 9 others
$316in research payments, 2019–2025

Across 1 payment — averaging $316.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$316

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,492,049 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Medicare billing

Part B allowed, 2024
$93,372
Medicare patients
257
Services billed
2,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Cheney

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →